Clinical Trial Update: Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating safety and efficacy of PF-04217329 in patients with primary open-angle glaucoma or ocular hypertension; results posted after stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• PF-04217329

Snippet

Sponsor: Pfizer | Conditions: Primary Open-Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2021-04-30